A detailed history of Oak Ridge Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Oak Ridge Investments LLC holds 52,042 shares of LLY stock, worth $40 Million. This represents 4.01% of its overall portfolio holdings.

Number of Shares
52,042
Previous 48,396 7.53%
Holding current value
$40 Million
Previous $43.8 Million 5.23%
% of portfolio
4.01%
Previous 4.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $2.82 Million - $3.5 Million
3,646 Added 7.53%
52,042 $46.1 Million
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $5.22 Million - $6.55 Million
-7,207 Reduced 12.96%
48,396 $43.8 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $1.2 Million - $1.61 Million
2,030 Added 3.79%
55,603 $43.3 Million
Q4 2023

Jan 16, 2024

BUY
$525.19 - $619.13 $407,547 - $480,444
776 Added 1.47%
53,573 $31.2 Million
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $653,354 - $900,747
1,503 Added 2.93%
52,797 $28.4 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $297,427 - $397,695
-848 Reduced 1.63%
51,294 $24.1 Million
Q1 2023

Apr 14, 2023

SELL
$310.63 - $364.82 $71,755 - $84,273
-231 Reduced 0.44%
52,142 $17.9 Million
Q4 2022

Jan 24, 2023

SELL
$321.55 - $374.67 $751,140 - $875,229
-2,336 Reduced 4.27%
52,373 $0
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $661,446 - $753,787
-2,231 Reduced 3.92%
54,709 $17.7 Million
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $495,581 - $581,886
-1,778 Reduced 3.03%
56,940 $18.5 Million
Q1 2022

Apr 22, 2022

SELL
$234.69 - $291.66 $835,731 - $1.04 Million
-3,561 Reduced 5.72%
58,718 $16.8 Million
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $379,996 - $471,577
-1,690 Reduced 2.64%
62,279 $17.2 Million
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $217,168 - $267,255
-980 Reduced 1.51%
63,969 $14.8 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $206,910 - $267,636
-1,146 Reduced 1.73%
64,949 $14.9 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $113 Million - $146 Million
-688,089 Reduced 91.24%
66,095 $12.3 Million
Q1 2021

May 04, 2021

BUY
$164.32 - $212.72 $113 Million - $146 Million
688,271 Added 1044.21%
754,184 $141 Million
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $3.23 Million - $4.28 Million
-24,774 Reduced 27.32%
65,913 $11.1 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $217,867 - $252,003
-1,490 Reduced 1.62%
90,687 $13.4 Million
Q2 2020

Aug 05, 2020

SELL
$136.42 - $164.18 $211,587 - $254,643
-1,551 Reduced 1.65%
92,177 $15.1 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $960,852 - $1.19 Million
-8,071 Reduced 7.93%
93,728 $13 Million
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $668,463 - $827,952
-6,252 Reduced 5.79%
101,799 $13.4 Million
Q3 2019

Nov 07, 2019

SELL
$106.79 - $116.16 $442,217 - $481,018
-4,141 Reduced 3.69%
108,051 $12.1 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $918,781 - $1.07 Million
-8,293 Reduced 6.88%
112,192 $12.4 Million
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $254,232 - $299,249
-2,284 Reduced 1.86%
120,485 $15.6 Million
Q4 2018

Feb 11, 2019

SELL
$105.9 - $118.64 $182,571 - $204,535
-1,724 Reduced 1.38%
122,769 $14.2 Million
Q3 2018

Nov 07, 2018

SELL
$85.86 - $107.31 $537,483 - $671,760
-6,260 Reduced 4.79%
124,493 $13.4 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $296,895 - $340,743
-3,922 Reduced 2.91%
130,753 $11.2 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $4.05 Million - $4.79 Million
-54,641 Reduced 28.86%
134,675 $10.4 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $639,132 - $685,542
-7,800 Reduced 3.96%
189,316 $16 Million
Q3 2017

Nov 07, 2017

SELL
$77.07 - $85.54 $1.57 Million - $1.75 Million
-20,401 Reduced 9.38%
197,116 $16.9 Million
Q2 2017

Aug 10, 2017

BUY
N/A
217,517
217,517 $17.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.